OneAscent Financial Services’s GSK GSK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$379K Buy
6,876
+2,207
+47% +$120K 0.02% 400
2025
Q4
$229K Buy
+4,669
New +$218K 0.02% 415
2025
Q3
Sell
-6,423
Closed -$249K 454
2025
Q2
$249K Sell
6,423
-1,277
-17% -$48.8K 0.02% 459
2025
Q1
$297K Buy
7,700
+292
+4% +$10.7K 0.02% 402
2024
Q4
$251K Buy
7,408
+1,495
+25% +$53.8K 0.02% 395
2024
Q3
$244K Sell
5,913
-243
-4% -$9.94K 0.18% 155
2024
Q2
$239K Sell
6,156
-1,097
-15% -$46.1K 0.03% 214
2024
Q1
$313K Sell
7,253
-158
-2% -$6.52K 0.03% 280
2023
Q4
$275K Buy
7,411
+17
+0.2% +$610 0.03% 285
2023
Q3
$268K Buy
+7,394
New +$262K 0.07% 196
2022
Q1
Sell
-4,448
Closed -$245K 168
2021
Q4
$245K Buy
+4,448
New +$231K 0.47% 97

Other funds holding GSK

OneAscent Financial Services's GSK Position: Q1 2026 in Review

OneAscent Financial Services increased its GSK (GSK) stake by 47% in Q1 2026, buying an estimated $120K and bringing the position to 6,876 shares worth $379K. The position accounts for 0.02% of the portfolio, ranked #400.

OneAscent Financial Services first reported a position in GSK in Q4 2021 and has held it in 11 quarters since. 1,032 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • OneAscent Financial Services held 6,876 shares of GSK worth $379K as of Q1 2026.
  • OneAscent Financial Services bought 2,207 GSK shares in Q1 2026, an estimated $120K.
  • GSK made up 0.02% of OneAscent Financial Services's portfolio in Q1 2026, its #400 holding.
  • OneAscent Financial Services first reported a position in GSK in Q4 2021 and has held it in 11 quarters since.
  • 1,032 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on OneAscent Financial Services's 13F filing for Q1 2026, filed 21 Apr 2026.